{"product_id":"innovage-five-forces-analysis","title":"InnovAge Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevate Your Analysis with the Complete Porter's Five Forces Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eInnovAge faces moderate buyer power and regulatory scrutiny, while supplier concentration and substitute care models exert measurable pressure on margins; new entrants are limited by specialized licensing and scale requirements. This brief snapshot only scratches the surface—unlock the full Porter's Five Forces Analysis to explore InnovAge’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eShortage of Specialized Geriatric Clinical Talent\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe primary suppliers for InnovAge are specialized clinicians—geriatricians, RNs, and physical therapists—whose national shortfall reached 1.4 million healthcare workers by 2025, giving them strong wage bargaining power. By late 2025 average RN vacancy-driven wage growth hit ~6–8% YoY, forcing InnovAge to raise labor costs to maintain PACE staff-to-participant ratios. Competitive pay and benefits now directly compress operating margins; labor is ~55–65% of PACE program costs, so a 7% wage rise cuts margins materially.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDependence on Specialized Health Information Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInnovAge depends on niche EHR and analytics platforms for the PACE model, giving vendors leverage as switching costs exceed $2m per site and 9–18 months of downtime risk. Vendors’ power rose as CMS reporting and 2025 data-security rules tightened, making suppliers critical for compliance and avoiding fines (median HIPAA-related fine in 2023: $2.5m).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Pharmaceutical and Medical Equipment Vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInnovAge buys large volumes of prescription drugs and durable medical equipment, giving some scale-based leverage, but 3 PBMs control about 80% of US prescription processing and top med-supply distributors handle ~70% of durable goods, limiting supplier options.\u003c\/p\u003e\n\u003cp\u003eIf late-2025 drug-price swings or supply shocks occur, InnovAge may face higher input costs it cannot pass on, since its Medicare Advantage and Medicaid managed care capitation rates are fixed—median MA payment growth was 3.5% in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReal Estate and Facility Management Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eInnovAge’s PACE centers need physical sites, so local real estate drives supplier power; in 2024 US urban office vacancy averaged 14.5%, yet medical-zoned space shortages in 50 largest metros push rents 8–20% above market for compliant properties.\u003c\/p\u003e\n\u003cp\u003eStrict healthcare zoning and ADA\/accessibility rules make relocations slow—per CBRE, redevelopment for medical use can take 9–18 months—giving landlords leverage at lease renewal and raising capex or rent negotiation costs.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDependence: PACE needs specialized sites, limited supply\u003c\/li\u003e\n\u003cli\u003eMarket: 2024 urban vacancy 14.5%, but medical-zoned scarce\u003c\/li\u003e\n\u003cli\u003eTime: conversion 9–18 months (CBRE)\u003c\/li\u003e\n\u003cli\u003eImpact: higher rent\/capex, strong landlord leverage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContracted Specialty Care and Hospital Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eInnovAge must contract external specialists and hospitals for services its centers lack; in many U.S. metro areas a single health system controls 50–70% of hospital beds, leaving InnovAge weak in rate negotiations for emergency and inpatient care.\u003c\/p\u003e\n\u003cp\u003eBecause PACE promises comprehensive care, dominant regional systems can raise prices or impose restrictive terms; for example, hospital consolidation raised inpatient prices by ~20–40% nationally between 2010–2020, increasing InnovAge cost risk.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDepends on external specialists\/hospitals\u003c\/li\u003e\n\u003cli\u003eDominant systems hold 50–70% beds in some regions\u003c\/li\u003e\n\u003cli\u003eConsolidation drove 20–40% higher inpatient prices (2010–2020)\u003c\/li\u003e\n\u003cli\u003eVulnerable to price hikes and restrictive contracts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier Power Cripples Margins: Clinician Shortages, EHR Lock‑In \u0026amp; PBM Dominance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold strong leverage: clinician shortages (1.4M shortfall by 2025) drive RN wage growth ~6–8% YoY, cutting margins (labor 55–65% of PACE costs); EHR\/vendor switching \u0026gt;$2M\/site and 9–18 months downtime raise vendor power; 3 PBMs handle ~80% prescription processing and top distributors ~70% durable goods, limiting sourcing; hospital systems control 50–70% beds regionally, pushing inpatient prices +20–40% (2010–2020).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSupplier\u003c\/th\u003e\n\u003cth\u003eKey stat\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinicians\u003c\/td\u003e\n\u003ctd\u003e1.4M shortfall (2025); RN wage +6–8% YoY\u003c\/td\u003e\n\u003ctd\u003eHigher labor cost; margins cut\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEHR\/vendors\u003c\/td\u003e\n\u003ctd\u003eSwitching \u0026gt;$2M\/site; 9–18 months\u003c\/td\u003e\n\u003ctd\u003eHigh lock-in; compliance risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePBMs\/distributors\u003c\/td\u003e\n\u003ctd\u003e3 PBMs 80%; top distro 70%\u003c\/td\u003e\n\u003ctd\u003eLimited pricing leverage\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003e50–70% beds regional share; inpatient +20–40%\u003c\/td\u003e\n\u003ctd\u003eHigher acute-care costs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter's Five Forces analysis for InnovAge that uncovers competitive drivers, buyer and supplier power, entry barriers, substitute threats, and strategic vulnerabilities to inform investor materials and corporate strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, one-sheet Porter's Five Forces snapshot tailored to InnovAge—instantly clarifies competitive pressures and helps prioritize strategic moves to reduce risk and protect margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentrated Power of Government Payers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe primary customers for InnovAge are the Centers for Medicare and Medicaid Services and state Medicaid agencies, which unilaterally set capitation rates InnovAge receives per participant. In 2025 CMS national benchmarks and state Medicaid rates constrained by fiscal deficits mean many rates have been flat since 2020 while long-term care costs rose ~3–5% annually. This concentrated buyer power compresses InnovAge margins and forces cost management or service trade-offs. States holding 10–30% of program funding can alone reshape local reimbursement.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Oversight and Audit Authority\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGovernment agencies act as both payer and regulator, giving them dual leverage over InnovAge operations and contracting decisions.\u003c\/p\u003e\n\u003cp\u003eFailure to meet CMS quality metrics or state compliance can trigger enrollment freezes or loss of PACE provider status; CMS cited 12 enrollee freezes and 3 provider terminations across programs in 2024.\u003c\/p\u003e\n\u003cp\u003eThis dynamic forces InnovAge to prioritize government-mandated quality outcomes and quarterly reporting—CMS Star-like measures, HEDIS components, and audit readiness—over other business goals to keep contracts and revenue streams intact.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFamily and Caregiver Decision Influence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpwhile the enrolled senior is participant family caregivers usually drive pace enrollment decision seeking relief from caregiving burdens and controlling provider choice.\u003e\u003cpfamilies wield high bargaining power because they can choose traditional home health assisted living medicaid waivers or innovage pace market substitution raises price and service sensitivity.\u003e\u003cpby late caregivers increasingly use online transparency tools and cms-style star ratings survey found of families checked local competition forcing innovage to match visible quality metrics.\u003e\n\u003c\/pby\u003e\u003c\/pfamilies\u003e\u003c\/pwhile\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLimited Switching Costs for Participants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eParticipants can disenroll from PACE at month-end and return to traditional Medicare\/Medicaid, creating very low switching costs that force InnovAge to keep satisfaction high to avoid churn.\u003c\/p\u003e\n\u003cp\u003eLoss of satisfaction in care quality, transport or day-center engagement can cost InnovAge the monthly capitation payment per participant—about $4,500–$6,000 on average in 2024 for dual-eligible seniors—so declines produce immediate revenue loss.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMonthly disenrollment possible\u003c\/li\u003e\n\u003cli\u003e2024 avg capitation ~$4,500–$6,000 per participant\u003c\/li\u003e\n\u003cli\u003eQuality\/transport\/engagement drive churn\u003c\/li\u003e\n\u003cli\u003eImmediate revenue impact per exit\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImpact of Referral Source Preferences\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHospital discharge planners and social workers act as powerful intermediaries, directing post-acute referrals and consolidating demand—studies show discharge referrals account for about 45% of post-acute placements in 2024, so their view of InnovAge’s effectiveness directly affects enrollment.\u003c\/p\u003e\n\u003cp\u003eMaintaining strong relationships with these gatekeepers is essential: a 2023 survey found 62% of planners prefer programs with clear outcomes reporting, and InnovAge risk losing clustered referrals if perceived efficacy drops.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e45% of post-acute placements from discharge planners (2024)\u003c\/li\u003e\n\u003cli\u003e62% of planners favor programs with outcomes reporting (2023)\u003c\/li\u003e\n\u003cli\u003eGatekeepers consolidate many seniors’ choices into few channels\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicaid caps, rising costs and quality hits squeeze InnovAge—high churn \u0026amp; regulator risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh buyer concentration: CMS\/state Medicaid set capitation (~$4,500–$6,000\/mo in 2024) and drove flat rates vs 3–5% cost inflation, squeezing InnovAge margins. Families\/caregivers and low switching costs raise churn risk; 62% check ratings (2024) and disenrollment is monthly. Discharge planners drive ~45% of placements, so gatekeeper relations affect volumes. Quality\/compliance failures led to 12 freezes, 3 terminations (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 avg capitation\u003c\/td\u003e\n\u003ctd\u003e$4,500–$6,000\/mo\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnnual LTC cost rise\u003c\/td\u003e\n\u003ctd\u003e3–5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFamilies checking ratings (2024)\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlacements from discharge planners (2024)\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS freezes\/terminations (2024)\u003c\/td\u003e\n\u003ctd\u003e12 freezes, 3 terminations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eInnovAge Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact InnovAge Porter's Five Forces analysis you'll receive immediately after purchase—no placeholders or mockups—fully formatted and ready for download and use the moment you buy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56746827612537,"sku":"innovage-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/innovage-five-forces-analysis.png?v=1772192239","url":"https:\/\/matrixbcg.com\/products\/innovage-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}